Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Conditional Cytotoxic Anti-HIV Gene Therapy for Selectable Cell Modification.

Human gene therapy - 1 May 2016

Garg Himanshu, Joshi Anjali

Abstract excerpt

Gene therapy remains one of the potential strategies to achieve a cure for HIV infection. One of the major limitations of anti-HIV gene therapy concerns recovering an adequate number of modified cells to generate an HIV-proof immune system. Our study addresses this issue by developing a methodology that can mark conditional vector-transformed cells for selection and subsequently target HIV-infected cells for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ganciclovir
Share to Gene Order
Share to Genes, Viral

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Therapy

Share to Lentivirus

Share to tat Gene Products, Human Immunodeficiency Virus

Share to Thymidine Kinase

Share to Transduction, Genetic

Source

Open in PubMed Open full text

Identifiers

PMID: 26800572
DOI: 10.1089/hum.2015.126
PMCID: PMC4841074

Genes

CXCR4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Conditional Cytotoxic Anti-HIV Gene Therapy for Selectable Cell Modification.PMID 26800572Read ↗

T cell transduction and suicide with an enhanced mutant thymidine kinase.Semantic proximity Read ↗

A Rev-inducible mutant gag gene stably transferred into T lymphocytes: an approach to gene therapy against human immunodeficiency virus type 1 infection.Semantic proximity Read ↗

A conditionally replicating HIV-1 vector interferes with wild-type HIV-1 replication and spread.Semantic proximity Read ↗

A mutant Tat protein provides strong protection from HIV-1 infection in human CD4+ T cells.Semantic proximity Read ↗

Progress towards gene therapy for HIV infection.Semantic proximity Read ↗

Exclusive Transduction of Human CD4+ T Cells upon Systemic Delivery of CD4-Targeted Lentiviral VectorsSemantic proximity Read ↗

Survival of the Fittest: Positive Selection of CD4+ T Cells Expressing a Membrane-Bound Fusion Inhibitor Following HIV-1 InfectionSemantic proximity Read ↗

Engineering HIV-Resistant, Anti-HIV Chimeric Antigen Receptor T CellsSemantic proximity Read ↗

Rapid protection against human immunodeficiency virus type 1 (HIV-1) replication mediated by high efficiency non-retroviral delivery of genes interfering with HIV-1 tat and gag.Semantic proximity Read ↗

Retroviral pseudotransduction for targeted cell manipulation.Semantic proximity Read ↗

Anti-HIV-1 HSPC-based gene therapy with safety kill switch to defend against and attack HIV-1 infectionSemantic proximity Read ↗

Highly Efficient and Selective CAR-Gene Transfer Using CD4- and CD8-Targeted Lentiviral VectorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.